Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulien G de Jong

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Reproduction Update|June 15, 2013
Antithrombotic therapy for pregnancy lossPaulien G de Jong, Mariëtte Goddijn, Saskia Middeldorp
British Journal of Haematology|June 28, 2012
Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long termPaulien G de Jong, Michiel Coppens, Saskia Middeldorp
Seminars in Reproductive Medicine|December 14, 2011
Testing for inherited thrombophilia in recurrent miscarriagePaulien G de Jong, Mariëtte Goddijn, Saskia Middeldorp
The Cochrane Database of Systematic Reviews|July 5, 2014
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophiliaPaulien G de Jong, Stef Kaandorp, Marcello Di Nisio, et al.
The Cochrane Database of Systematic Reviews|January 27, 2017
Imaging for the exclusion of pulmonary embolism in pregnancyThijs E van Mens, Luuk Jj Scheres, Paulien G de Jong, et al.
British Journal of Haematology|November 11, 2014
No association between Annexin A5 genetic variants and deep venous thrombosisPaulien G de Jong, Larissa Hiddink, Joost C M Meijers, et al.
Thrombosis Research|April 17, 2020
Progress of the ALIFE2 study: A dynamic road towards more evidenceEva N Hamulyák, Paulien G de Jong, Luuk J J Scheres, et al.
Lancet (London, England)|June 4, 2023
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trialSiobhan Quenby, Katie Booth, Louise Hiller, et al.
Trials|May 8, 2015
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trialPaulien G de Jong, Siobhan Quenby, Kitty W M Bloemenkamp, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Reproduction Update|June 15, 2013
Antithrombotic therapy for pregnancy lossPaulien G de Jong, Mariëtte Goddijn, Saskia Middeldorp
British Journal of Haematology|June 28, 2012
Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long termPaulien G de Jong, Michiel Coppens, Saskia Middeldorp
Seminars in Reproductive Medicine|December 14, 2011
Testing for inherited thrombophilia in recurrent miscarriagePaulien G de Jong, Mariëtte Goddijn, Saskia Middeldorp
The Cochrane Database of Systematic Reviews|July 5, 2014
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophiliaPaulien G de Jong, Stef Kaandorp, Marcello Di Nisio, et al.
The Cochrane Database of Systematic Reviews|January 27, 2017
Imaging for the exclusion of pulmonary embolism in pregnancyThijs E van Mens, Luuk Jj Scheres, Paulien G de Jong, et al.
British Journal of Haematology|November 11, 2014
No association between Annexin A5 genetic variants and deep venous thrombosisPaulien G de Jong, Larissa Hiddink, Joost C M Meijers, et al.
Thrombosis Research|April 17, 2020
Progress of the ALIFE2 study: A dynamic road towards more evidenceEva N Hamulyák, Paulien G de Jong, Luuk J J Scheres, et al.
Lancet (London, England)|June 4, 2023
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trialSiobhan Quenby, Katie Booth, Louise Hiller, et al.
Trials|May 8, 2015
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trialPaulien G de Jong, Siobhan Quenby, Kitty W M Bloemenkamp, et al.
Pageof 1